During the past decade, General Practice Schelp conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "General Practice Schelp" are "Urinary Tract Infections" (2 trials). Many other conditions were trialed in "General Practice Schelp" in a lesser frequency.

Most popular intervention types in "General Practice Schelp" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Arctuvan" (2 trials), "Fosfomycin" (2 trials), "Placebo to Arctuvan" (2 trials) and "Placebo to Fosfomycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "General Practice Schelp" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "General Practice Schelp". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in General Practice Schelp, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Practice Schelp, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".